Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F G Salituro

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of Medicinal Chemistry|June 1, 1983
Synthesis of analogues of pepstatin. Effect of structure in subsites P1', P2', and P2 on inhibition of porcine pepsinD H Rich, F G Salituro
European Journal of Pharmacology|January 14, 1997
Enzyme-catalyzed production of the neuroprotective NMDA receptor antagonist 7-chlorokynurenic acid in the rat brain in vivoH Q Wu, F G Salituro, R Schwarcz
Journal of Medicinal Chemistry|February 1, 1987
Synthetic and enzyme inhibition studies of pepstatin analogues containing hydroxyethylene and ketomethylene dipeptide isosteresM W Holladay, F G Salituro, D H Rich
Journal of Medicinal Chemistry|February 1, 1987
Inhibition of aspartic proteinases by peptides containing lysine and ornithine side-chain analogues of statineF G Salituro, N Agarwal, T Hofmann, et al.
Biochemical and Biophysical Research Communications|June 14, 1985
Identification of oxygen nucleophiles in tetrahedral intermediates: 2H and 18O induced isotope shifts in 13C NMR spectra of pepsin-bound peptide ketone pseudosubstratesP G Schmidt, M W Holladay, F G Salituro, et al.
Steroids|November 1, 1986
[125I]iododesethyl tamoxifen aziridine: synthesis and covalent labeling of the estrogen receptor with an iodine-labeled affinity labelF G Salituro, K E Carlson, J F Elliston, et al.
Current Medicinal Chemistry|September 25, 1999
Inhibitors of p38 MAP kinase: therapeutic intervention in cytokine-mediated diseasesF G Salituro, U A Germann, K P Wilson, et al.
Biochemistry|June 18, 1985
Inhibition of aspartic proteases by pepstatin and 3-methylstatine derivatives of pepstatin. Evidence for collected-substrate enzyme inhibitionD H Rich, M S Bernatowicz, N S Agarwal, et al.
Mini Reviews in Medicinal Chemistry|March 23, 2004
Kinase chemogenomics: targeting the human kinome for target validation and drug discoveryE ter Haar, W P Walters, S Pazhanisamy, et al.
Journal of Medicinal Chemistry|May 15, 1992
3-(2-Carboxyindol-3-yl)propionic acid-based antagonists of the N-methyl-D-aspartic acid receptor associated glycine binding siteF G Salituro, B L Harrison, B M Baron, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Medicinal Chemistry|June 1, 1983
Synthesis of analogues of pepstatin. Effect of structure in subsites P1', P2', and P2 on inhibition of porcine pepsinD H Rich, F G Salituro
European Journal of Pharmacology|January 14, 1997
Enzyme-catalyzed production of the neuroprotective NMDA receptor antagonist 7-chlorokynurenic acid in the rat brain in vivoH Q Wu, F G Salituro, R Schwarcz
Journal of Medicinal Chemistry|February 1, 1987
Synthetic and enzyme inhibition studies of pepstatin analogues containing hydroxyethylene and ketomethylene dipeptide isosteresM W Holladay, F G Salituro, D H Rich
Journal of Medicinal Chemistry|February 1, 1987
Inhibition of aspartic proteinases by peptides containing lysine and ornithine side-chain analogues of statineF G Salituro, N Agarwal, T Hofmann, et al.
Biochemical and Biophysical Research Communications|June 14, 1985
Identification of oxygen nucleophiles in tetrahedral intermediates: 2H and 18O induced isotope shifts in 13C NMR spectra of pepsin-bound peptide ketone pseudosubstratesP G Schmidt, M W Holladay, F G Salituro, et al.
Steroids|November 1, 1986
[125I]iododesethyl tamoxifen aziridine: synthesis and covalent labeling of the estrogen receptor with an iodine-labeled affinity labelF G Salituro, K E Carlson, J F Elliston, et al.
Current Medicinal Chemistry|September 25, 1999
Inhibitors of p38 MAP kinase: therapeutic intervention in cytokine-mediated diseasesF G Salituro, U A Germann, K P Wilson, et al.
Biochemistry|June 18, 1985
Inhibition of aspartic proteases by pepstatin and 3-methylstatine derivatives of pepstatin. Evidence for collected-substrate enzyme inhibitionD H Rich, M S Bernatowicz, N S Agarwal, et al.
Mini Reviews in Medicinal Chemistry|March 23, 2004
Kinase chemogenomics: targeting the human kinome for target validation and drug discoveryE ter Haar, W P Walters, S Pazhanisamy, et al.
Journal of Medicinal Chemistry|May 15, 1992
3-(2-Carboxyindol-3-yl)propionic acid-based antagonists of the N-methyl-D-aspartic acid receptor associated glycine binding siteF G Salituro, B L Harrison, B M Baron, et al.
Pageof 2